MetLife Investment Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $109K | Buy |
28,332
+233
| +0.8% | +$892 | ﹤0.01% | 2505 |
|
|
2025
Q1 | $162K | Sell |
28,099
-590
| -2% | -$3.39K | ﹤0.01% | 2307 |
|
|
2024
Q4 | $143K | Hold |
28,689
| – | – | ﹤0.01% | 2466 |
|
|
2024
Q3 | $155K | Hold |
28,689
| – | – | ﹤0.01% | 2423 |
|
|
2024
Q2 | $95K | Buy |
28,689
+3,883
| +16% | +$12.9K | ﹤0.01% | 2634 |
|
|
2024
Q1 | $81.1K | Buy |
24,806
+125
| +0.5% | +$409 | ﹤0.01% | 2625 |
|
|
2023
Q4 | $86.6K | Hold |
24,681
| – | – | ﹤0.01% | 2663 |
|
|
2023
Q3 | $165K | Hold |
24,681
| – | – | ﹤0.01% | 2314 |
|
|
2023
Q2 | $207K | Buy |
+24,681
| New | +$207K | ﹤0.01% | 2257 |
|
|
2022
Q2 | – | Sell |
-14,311
| Closed | -$63.6K | – | 2856 |
|
|
2022
Q1 | $63.6K | Sell |
14,311
-4,404
| -24% | -$19.6K | ﹤0.01% | 2661 |
|
|
2021
Q4 | $74.9K | Buy |
18,715
+9,298
| +99% | +$37.2K | ﹤0.01% | 2456 |
|
|
2021
Q3 | $82.7K | Sell |
9,417
-9,627
| -51% | -$84.5K | ﹤0.01% | 2499 |
|
|
2021
Q2 | $216K | Buy |
+19,044
| New | +$216K | ﹤0.01% | 2120 |
|